|
![]() |
|||
|
||||
OverviewFull Product DetailsAuthor: Ric M. Procyshyn , Kalyna Z. Bezchlibnyk-Butler , Joel J. JeffriesPublisher: Hogrefe Publishing Imprint: Hogrefe Publishing Edition: 21st Revised edition ISBN: 9781616764746ISBN 10: 1616764740 Pages: 408 Publication Date: 01 May 2015 Audience: Professional and scholarly , General/trade , Professional & Vocational , General Format: Electronic book text Publisher's Status: Active Availability: Available To Order ![]() We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately. Table of ContentsAntidepressantsSelective Serotonin Reuptake Inhibitors (SSRI) * Norepinephrine Dopamine Reuptake Inhibitor (NDRI) * Serotonin NorepinephrineReuptake Inhibitor (SNRI) * Serotonin-2 Antagonists/Reuptake Inhibitors (SARI) * Serotonin-1A Agonist/Serotonin Reuptake Inhibitor* Serotonin Stimulator / Serotonin Modulator * Noradrenergic/Specific Serotonergic Antidepressants (NaSSA) * Nonselective CyclicAntidepressants * Monoamine Oxidase Inhibitors * Reversible Inhibitor of MAO-A (RIMA) * Irreversible Monoamine Oxidase (A&B)Inhibitors (MAOIs) * Irreversible MAO-B Inhibitor * Effects of Antidepressants on Neurotransmitters/Receptors * Pharmacological Effectsof Antidepressants on Neurotransmitters/Receptors * Frequency of Adverse Reactions to Antidepressants at Therapeutic Doses *Antidepressant Doses and Pharmacokinetics * Switching Antidepressants * Antidepressant Augmentation StrategiesElectroconvulsive Therapy (ECT)Bright Light Therapy (BLT)Repetitive Transcranial Magnetic Stimulation (rTMS)Antipsychotics Second-Generation Antipsychotics/SGAs * Third-Generation Antipsychotic/TGA * First-Generation Antipsychotics/FGAs * Effectsof Antipsychotics on Neurotransmitters/Receptors * Pharmacological Effects of Antipsychotics on Neurotransmitters/ReceptorSubtypes * Relative Tolerability Profiles of Antipsychotics * Frequency of Adverse Reactions to Antipsychotics at Therapeutic Doses *Antipsychotic Doses and Pharmacokinetics (Oral and Short-Acting Injections) * Comparison of Long-Acting IM Antipsychotics * SwitchingAntipsychotics * Antipsychotic Augmentation StrategiesAntipsychotic-Induced Extrapyramidal Side Effects and Their ManagementExtrapyramidal Adverse Effects of Antipsychotics * Treatment Options for Extrapyramidal Side Effects * Effects on ExtrapyramidalSymptoms * Comparison of Agents for Treating Acute Extrapyramidal Side Effects * Doses and Pharmacokinetics of Agents for TreatingAcute Extrapyramidal Side EffectsAnxiolytic (Antianxiety) AgentsBenzodiazepines * Comparison of the Benzodiazepines * BuspironeHypnotics/SedativesL-Tryptophan * Comparison of Hypnotics/SedativesMood StabilizersLithium * Anticonvulsants * Comparison of Anticonvulsants * Frequency of Adverse Reactions to Mood Stabilizers at Therapeutic DosesDrugs for ADHDPsychostimulants * Atomoxetine * Comparison of Drugs for ADHD * alpha2 Agonists * Augmentation Strategies in ADHDDrugs for Treatment of DementiaCholinesterase Inhibitors * Memantine * Comparison of Drugs for Treatment of DementiaSex-Drive DepressantsComparison of Sex-Drive DepressantsDrugs of AbuseAlcohol * Stimulants * Hallucinogens * Opioids * Inhalants/Aerosols * Gamma-hydroxybutyrate (GHB)/Sodium Oxybate * Flunitrazepam(Rohypnol) * Nicotine/TobaccoTreatment of Substance Use DisordersAcamprosate * Disulfiram * Naltrexone * Buprenorphine * Methadone * Pharmacotherapy for Nicotine/Tobacco Use DependenceUnapproved Treatments of Psychiatric DisordersAdrenergic Agents * Dopaminergic Agents * GABA Agents/Anticonvulsants * Hormones * NMDA Agents * MiscellaneousNatural Health ProductsPharmacogenomic Information for Common Psychiatric DrugsGlossaryResources for Information on Drug Use in Pregnancy and Effects on Breast MilkNeuroscience-Based NomenclaturePatient Information SheetsIndex of DrugsReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |